🇺🇸 FDA
Patent

US 12084431

Pharmaceutical salts of pyrimidine derivatives and method of treating disorders

granted A61PA61P35/00

Quick answer

US patent 12084431 (Pharmaceutical salts of pyrimidine derivatives and method of treating disorders) held by Takeda Pharmaceutical Company Limited expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P35/00